DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

Galmed Pharmaceuticals Q4 EPS $(0.39) Misses $(0.34) Estimate

Galmed Pharmaceuticals (NASDAQ:GLMD) reported quarterly losses of $(0.39) per share which missed the analyst consensus estimate of $(0.34) by 14.71 percent. This is a 116.67 percent decrease over losses of $(0.18) per

Benzinga · 03/12/2020 11:06

Galmed Pharmaceuticals (NASDAQ:GLMD) reported quarterly losses of $(0.39) per share which missed the analyst consensus estimate of $(0.34) by 14.71 percent. This is a 116.67 percent decrease over losses of $(0.18) per share from the same period last year.